Blood Levels of microRNAs May Serve as Diagnostic Tool for Thyroid Cancer, But More Research Needed, University of Sydney Study

free biotech news

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A new analysis has found that the presence of short segments of genetic material (known as microRNA) within papillary thyroid cancer tumors suggests a likelihood of recurrence after patients undergo surgery. The study, which is published early online in CANCER, a peer-reviewed journal of the American Cancer Society, also found that elevated blood levels of the genetic material after surgery may indicate a higher possibility of recurrence after thyroidectomy.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC